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Signal transduction pathways induced by cytokines can modulate the level of HIV-1 gene transcription and replication in
a variety of cells including those from the central nervous system. Here, we investigated the effect of TGF-1 signaling the
factors, including Smads, on transcription of the viral LTR in human astrocytic cells. Ectopic expression of Smad-3 increased
activity of the viral promoter, while its partner protein, Smad-4, caused a slight decrease in viral gene transcription. Further,
Smad-4 was able to suppress transcriptional activation of the LTR by Smad-3 as well as by C/EBP, another activator of LTR
transcription in these cells. Results from promoter deletion experiments identified the C/EBP-binding site, which is positioned
between nucleotides 114 and 102 as one of the targets for Smad-mediated regulation of the LTR. Band-shift studies
showed inhibition of C/EBP binding to its target DNA in protein extract from cells overexpressing Smad-3 and Smad-4.
Results from GST pull-down assay and combined immunoprecipitation/Western blot of protein extracts from human
astrocytes verified the association of Smad-3 and Smad-4 with C/EBP, suggesting that interaction of C/EBP with Smad-3
and Smad-4 may have a negative impact upon C/EBP-mediated activation of the LTR. Interestingly, Smad-4 showed no
inhibitory effect on viral gene transcription in cells expressing Tat protein. However, in the presence of Smad-3, expressionThe HIV-1 LTR DNA sequence is composed of several
distinct regulatory motifs, each exerting their role on the
transcription of the viral genome by interacting with cel-
lular DNA binding transcription factors (for review see
Pereira et al., 2000). Some of the participant transcription
factors are inducible and the level of their expression
and/or activities in cells is regulated by external stimuli
such as cytokines and immunomodulators (Atwood et al.,
1994; Kumar et al., 1996). Several inflammatory cytokines
such as interleukin 1 (IL-1), tumor necrosis factor 
(TNF), and transforming growth factor  (TGF) whose
levels are elevated in patients with AIDS (Tyor et al.,
1992) have the capacity to mediate activation of several
cellular and viral genes through distinct signaling path-
ways (Corley, 2000; Jeeninga et al., 2000; Li et al., 1998).
For example, TNF and IL-1, through the IB/NFB path-
way, mediate nuclear transportation of p50 and p65 sub-
units of NFB where they bind to the B DNA motif and
stimulate transcription of the corresponding genes
(Arenzana-Seisdedos et al., 1995; Beg et al., 1993). The
TGF-1 pathway, on the other hand, operates through the
Smad family of transcription factors that transmits sig-
nals from TGF-1 receptors to target genes in the nu-© 2002 Elsevier Science (USA)
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240cleus (Heldin et al., 1997; Piek et al., 1999). For instance,
the interaction of Smad-3 and Smad-4 results in nuclear
import of this heterodimer and association of Smad-3:
Smad-4 with the promoter DNA sequences and/or other
regulatory proteins controls transcription of a distinct set
of target genes (Xiao et al., 2000; Zhang et al., 1998).
In previous studies, we and others have demonstrated
an enhanced level of several critical cytokines, particu-
larly TGF-1, upon expression of HIV-1 infection of astro-
cytes and other cells, or treatment of these cells with Tat
protein (Cupp et al., 1993; Gallo et al., 1989; Lotz et al.,
1990; Poli and Fauci, 1992; Rasty et al., 1996; Sawaya et
al., 1998; Thatikunta et al., 1997; Wahl et al., 1991; Zauli et
al., 1992). Interestingly, some of these cytokines can
regulate HIV-1 replication in various cells including
monocytic/macrophage and glial cells (Lazdins et al.,
1991; Poli et al., 1991; Vitkovic and da Cunha, 1995). Here,
we investigated the regulation of LTR transcription by
TGF-1 signaling pathway to gain some information on
the cooperativity between various cellular proteins in-
duced upon HIV-1 infection that may modulate viral gene
expression and replication.
In the first series of experiments, we tested the effect
of Smad-3 and Smad-4 on LTR promoter activity by trans-of Smad-4 exerted a negative effect on Tat-mediated act
functional interplay between viral and cellular proteins in m
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fection of human astrocytic cells, U-87MG. In parallel, the
effect of p50 and p65 subunits of NFB on transcriptionivation
odulat
of the LTR was examined. As anticipated, and in accord
with previous observations (Nabel and Baltimore, 1987),
ectopic expression of p50 had a modest effect on LTR
transcription, while its activator partner, p65, showed a
more positive effect on the transcription of the viral pro-
moter. Further, coexpression of p50/p65 in cells resulted
in a noticeable enhancement in transcription of the HIV-1
LTR (Fig. 1). Expression of Smad-3 caused a drastic
increase in transcription of the viral promoter, whereas
under similar conditions Smad-4 expression did not alter
basal CAT activity. Interestingly, coexpression of Smad-3
and Smad-4 caused a substantial decrease in the tran-
scriptional activation of the LTR by Smad-3, suggesting
that the intracellular levels of these two proteins may
determine the basal activity of HIV-1 gene transcription in
astrocytes (Fig. 1). It is important to note that the ob-
served Smad-4-mediated inhibition of the HIV-1 LTR is
not a general event, as under similar conditions, Smad-4
showed no inhibitory effect upon SV40 early promoter
activity (data not shown). To investigate the effect of
TGF-1 on the activity of Smad-3 and Smad-4 upon LTR
transcription, U-87MG cells were transfected with LTR-
CAT reporter construct plus Smad-3 and Smad-4 expres-
sion plasmids in the presence and absence of TGF-1.
As shown in Fig. 2, treatment of these cells with TGF-1
increased the basal level of LTR transcription (compare
lanes 1 in panels A and B). Further induction of the LTR
by Smad-3 was less noticeable in the TGF-1-treated
cells (Fig. 2B). This observation suggests that under
these experimental conditions, cells may maximally re-
spond to TGF-1 stimulation and that Smad-3 may exert
no significant effect upon viral gene activity. On the other
hand, Smad-4 was able to decrease activation of the viral
promoter in TGF-1-treated cells.
Results from DNA-binding experiments showed no
strong and specific association of Smad proteins with
the viral DNA promoter sequences, suggesting that the
observed regulatory event may be mediated indirectly
and via interaction with other cellular proteins. Examina-
tion of various promoter deletion mutants led us to be-
lieve that the sequence downstream from 117 of the
LTR may play a more important role in the observed
regulatory event (data not shown). C/EBP represents
one of the potent DNA-binding transcriptional activators
of the LTR whose binding site resides between nucleo-
tides 114 and 102, providing a rationale to study the
involvement of this protein in TGF-1 signaling events.
To investigate the possible cooperativity between
C/EBP and TGF-1 pathways, we examined the func-
tional interaction of C/EBP with Smad-3 and Smad-4 in
U-87MG cells transfected with the full-length LTR pro-
moter construct. As shown in Fig. 3, ectopic expression
of C/EBP enhanced the transcriptional activity of the
viral full-length promoter and that both Smad-3, and to a
higher level, Smad-4 were able to decrease viral gene
transcription in U-87MG cells. Again, coexpression of
FIG. 2. Transcriptional activity of HIV-1 LTR by Smads in cells treated
with TGF-1. U-87MG cells were maintained in serum-free media for
4 h prior to transfection with 2 g of full-length LTR-CAT and pcDNA-
based Smads expression plasmid DNAs. After transfection, cells were
maintained in DMEM containing 10% Serum Plus (JRH Biosciences) in
the absence (A) or presence (B) of 0.2 ng/ml TGF-1. CAT enzymatic
activity was determined after 48 h and the percentage conversion was
identified by scintillation counting.
FIG. 1. Activation of HIV-1 LTR transcription by NF-B and Smad
subunits in astrocytes. Approximately 105 U-87MG cells were trans-
fected with 2 g of a plasmid containing full-length LTR DNA (450 to
80) fused to the CAT gene in the absence and presence of 5 g of
plasmids expressing p50, p65, Smad-3, and Smad-4 as indicated above
the lanes. These expressor plasmids were generated using pcDNA
backbone. DNA concentrations were kept constant by adding empty
vector DNA (pcDNA). After 48 h, CAT activity was measured and the
percentage conversion of chloramphenicol to its acetylated forms was
determined (as described in Cupp et al., 1993). All CAT experiments
shown in this and other figures were repeated several times and
standard variations between 15 to 20% were observed.
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Smad-3 and Smad-4 showed a drastic effect on viral
promoter activation by C/EBP. These data suggest that
TGF-1 signaling factors may modulate transcription of
the LTR, at least in part, via the C/EBP transcription factor.
To exclude the involvement of a large group of transcrip-
tion factors whose binding sites reside at regions up-
stream from the C/EBP-binding site, a deletion mutant
promoter that removes the sequences between 486
and117 and retains the region between117 and80
which encompasses the C/EBP-binding site at positions
between114 and102 was used in transfection assay.
As shown in Fig. 3B, the activity of this deletion promoter
was enhanced by C/EBP. While Smad-3 showed no
negative effect on the C/EBP transcriptional activity, no
further enhancement on viral gene transcription above
the level seen by C/EBP alone was observed. As before,
Smad-4 decreased LTR activity in the presence of
C/EBP and Smad-3. These observations suggest that
the functional interplay between C/EBP and Smads may
be mediated via the C/EBP-binding sites at nucleotides
114 to 102, and that Smads may determine the asso-
ciation of C/EBP with its target DNA. As such, in the next
series of experiments, we investigated DNA-binding ac-
tivity of C/EBP in the presence and absence of Smad-3
and Smad-4. Nuclear extracts from U-87MG or U-87MG
transfected with C/EBP plasmid were incubated with
oligonucleotide DNA probes containing the HIV-1 C/EBP-
binding site. As shown in Fig. 4A, a single intense band
was detected upon incubation of U-87MG protein extract
with the C/EBP probe. The intensity of the band was
decreased, but not abolished, in the presence of 100-
and 200-fold excess of mutant DNA competitor with al-
tered nucleotides at the binding site of C/EBP. However,
formation of the complex was drastically reduced in the
presence of wild-type DNA competitor, suggesting the
comigration of a nonspecific DNA protein complex with a
similar electrophoretic mobility as the C/EBP:DNA com-
plex. To alleviate this nonspecific background, in the next
experiment, an excess amount of mutant competitor
DNA (200-fold molar excess) was incubated with wild-
type DNA probe in all binding reactions. As shown in Fig.
4B, the intensity of the band corresponding to C/EBP was
enhanced in the cell extract that was transfected with
C/EBP plasmid and overexpressed this protein (compare
lanes 1 and 2), further verifying the association of C/EBP
with the C/EBP DNA probe. Interestingly, the intensity of
the C/EBP nucleoprotein complex was decreased in
cells expressing C/EBP along with Smad-3 or Smad-4,
and completely abrogated in cells coexpressing all three
proteins. It should be noted that the absence of the
complex was not due to an inefficient process of trans-
fection or protein degradation. The evidence supporting
this notion came from Western blot analysis using cell
extracts from transfected cells and antibody against the
exogenously expressed protein. The absence of alterna-
tive bands in these reactions suggests that Smad-3 and
Smad-4 may inhibit interaction of C/EBP with its target
DNA sequence without being associated with the C/EBP
FIG. 3. Effect of Smad-3 and Smad-4 on C/EBP activation of the LTR. U-87MG cells were transfected with 2 g of full-length LTR-CAT (A) or 2 g
of a plasmid containing segments of the LTR between 117 and 80 fused to the CAT gene (B) in the absence or presence of 5 g plasmids
expressing C/EBP, Smad-3, or Smad-4 in various combinations. It should be noted that the C/EBP expressor plasmid was generated on an MSV-based
vector (Schwartz et al., 2000). The relative CAT activity is an average of multiple experiments and presented as fold effects with a baseline (lane 1)
remaining as an arbitrary unit of 1. As before, the concentration of DNA in each transfection mixture remained constant by adding empty plasmid DNA.
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DNA-binding site. Thus, it is likely that communication
between C/EBP and Smads may also occur independent
from its target DNA sequence via protein–protein inter-
action.
To examine the association of C/EBP with Smad-3 and
Smad-4, U-87MG cells were transiently transfected with
C/EBP expression plasmid. Nuclear extract was pre-
pared after 48 h and incubated with GST, GST-Smad-3,
and GST-Smad-4 fusion proteins coupled to glutathione
Sepharose beads. Bound proteins were analyzed by
Western blot using anti-C/EBP antibody. As shown in Fig.
5A, C/EBP was bound by GST-Smad-4 and GST-Smad-3
plus GST-Smad-4, but not by the GST-Smad-3 alone or
GST. Examination of GST-Smad-3 and GST-Smad-4 pro-
tein levels in each binding reaction by SDS–PAGE
showed that equal amounts of these fusion proteins
were present in each binding reaction (Fig. 5B). In an-
other series of experiments, cells were transfected with
plasmids expressing Smad-4 alone or together with
C/EBP and Smad-3. After 48 h, nuclear extracts were
prepared and immunoprecipitated using the control se-
rum (NS) or anti-Smad-4 and anti-C/EBP antibodies. The
immunocomplexes were analyzed by SDS–PAGE fol-
lowed by Western blot analysis using anti-Smad-4 anti-
body. As shown in Fig. 5C, the immunocomplex that was
pulled down by normal serum upon incubation of the
Smad-4-transfected cell extract showed no sign corre-
sponding to Smad-4, whereas the immunocomplex ob-
tained from the same cell extract upon incubation with
anti-Smad-4 showed a strong signal corresponding to
Smad-4. Incubation of protein extract from cells that
overexpressed C/EBP and Smad-4 with anti-C/EBP anti-
body resulted in the formation of an immunocomplex that
had no significant (detectable) level of Smad-4. Never-
theless, this observation led to the speculation that Smad-4
and anti-C/EBP may recognize the same epitope within
C/EBP and association of one protein with C/EBP may
diminish/exclude the interaction of this protein with the
other one. Interestingly, coproduction of Smad-3 and -4
together in cells expressing C/EBP alleviated this prob-
lem and the observed complex which was pulled down
by anti-C/EBP antibody showed a band corresponding to
FIG. 4. Interaction of C/EBP with LTR DNA sequence. (A) Ten micrograms of nuclear extract from U-87MG cells were incubated with 32P-labeled
double-stranded oligonucleotide DNA (5-AGATTTCTACAA-3) in the absence (lane 1) or presence of 100- and 200-fold molar excess of unlabeled
mutant oligonucleotide DNA competitor (5-AGTTTTCTACAA-3) (lanes 2 and 3, respectively) or unlabeled wild-type oligonucleotide (lane 4) under
conditions described previously (Taylor et al., 1994). The complexes were analyzed by native polyacrylamide gel. The position of the complexes is
shown by an arrow, and P depicts the position of the probe. (B) Nuclear extract from untransfected (lane 1) or cells transfected with C/EBP expressor
plasmid (lane 2), C/EBP plus Smad-3 (lane 3), C/EBP plus Smad-4 (lane 4), and C/EBP plus Smad-3 and Smad-4 expressor plasmids (lane 5) was
incubated with wild-type C/EBP-labeled probe in the presence of 200-fold excess of the mutant unlabeled DNA. The complex was analyzed by PAGE.
The position of C/EBP complex is shown by an arrow.
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Smad-4. These data suggest the interaction of Smad-4
with C/EBP in cell extracts containing both proteins.
Indeed, one may also speculate that the efficient in vivo
interaction of C/EBP with Smad-4 requires the presence
of Smad-3. Support for this notion comes from band-shift
data, where the association of C/EBP with its target DNA
was completely abrogated in the presence of both
Smad-3 and -4, implying that the interaction of Smad-3
and Smad-4 with C/EBP dissociates this protein from its
DNA consensus motif. Altogether these observations
strongly suggest that C/EBP associates with Smads and
such an interaction, either in the presence or absence of
DNA, may modulate C/EBP activity on the basal LTR
transcription.
As the basal transcription of the LTR is enhanced by
the viral transactivator, Tat, in the next series of experi-
ments, we investigated the effects of Smad-3 and
Smad-4 on Tat activation of the full-length LTR promoter
construct. As shown in Fig. 6, the basal activity of the LTR
(450 to 80) was significantly enhanced by Tat in
U-87MG (compare lanes 1 and 2 in panels A and B).
Inclusion of Smad-3 in transfection enhanced overall
transcription of the LTR promoter construct. Interestingly,
expression of Smad-4 slightly elevated the level of LTR
transcription in the presence of Tat suggesting that Tat,
by cooperating with Smad-4, may alleviate the negative
activity of Smad-4 upon viral gene transcription. How-
ever, coproduction of Smad-3 and Smad-4 decreased the
overall level of Tat-mediated transcription of the LTR,
again suggesting that intracellular levels of Smad-3 and
Smad-4 may determine the level of viral gene activation
by Tat.
In this report, we present evidence for cooperativity
between TGF signaling regulators, including Smad-3
and Smad-4, and C/EBP transcription factor in modula-
tion of HIV-1 LTR promoter activity. Earlier studies
showed that expression of C/EBP enhances transcrip-
tional activity of LTR in macrophages/monocytes (Hen-
derson et al., 1995). Further, it was demonstrated that
C/EBP is required for HIV-1 replication in monocytic
cells, and that the C/EBP-binding site within the LTR is
pivotal for its function (Henderson et al., 1996). In more
FIG. 6. Effect of Smads on Tat activation of the LTR. U-87MG cells
were transfected with 2 g of full-length LTR CAT plasmid (450 to
80) in the absence or presence of 0.5 g of a plasmid expressing Tat
along with Smad-3 and Smad-4 expression plasmid as described in the
legend to Fig. 1. CAT enzymatic activity was determined after 48 h and
the quantitative values were obtained as described in the legends to
the previous figures.
FIG. 5. Association of C/EBP with Smad-4. (A) Three hundred micro-
grams of whole cell extract from U-87MG cells transfected with a
C/EBP expressor plasmid were incubated with 3 g GST (lane 1),
GST-Smad-3 (lane 2), GST-Smad-4, and GST-Smad-3 and -4 attached to
glutathione-Sepharose resin. The bound proteins were analyzed by
SDS–PAGE followed by Western blot using anti-C/EBP antibody. The
position of C/EBP is shown by an arrow. (B) Smad-3, Smad-4, and both
Smad-3 and -4 which were used in binding experiments were analyzed
by SDS–PAGE and the positions of fusion proteins are shown by the
arrows. (C) U-87MG cells were transfected with Smad-4 (lanes 2 and 3),
C/EBP plus Smad-4 (lane 4), or C/EBP plus Smad-3 and Smad-4.
Nuclear extracts were prepared from the transfected cells and were
treated with normal serum (NS) or anti-Smad-4, anti-C/EBP antibodies
as indicated below the figure and analyzed by Western blot using
anti-Smad-4 antibody. The position of Smad-4 is shown by an arrow.
Lane 1 showed Western blot analysis of untransfected cell protein
extract (50 g) that is used to demonstrate the position of Smad-4 in the
blot.
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recent reports, evidence was provided for the impor-
tance of C/EBP in determining LTR transcriptional activity
during invasion and maintenance of the virus in the CNS
(Ross et al., 2001a,b). Activation of the viral promoter
which results in the production of several viral regulatory
proteins, such as Tat, can potentiate the expression of
several important cytokines and immunomodulators
which through signal transduction pathways may affect
expression of several cellular and viral genes. The most
studied pathway which mutually communicates with
both virus and host cells includes tumor necrosis factor
alpha (TNF) whose level is increased upon viral infec-
tion (Smith et al., 1992), and by autocrine and paracrine
mechanisms triggering signaling that eventually results
in activation of NF-B subunits of transcription factors
(Rostasy et al., 2000). Binding of the active NF-B p50/
p65 to the B motif of the LTR and their interaction with
the other regulatory proteins, in turn, maximizes the ex-
pression of the viral genome (Perkins et al., 1993). The
TGF signaling pathway, which is also activated by HIV-1
in astrocytic cells, can exert a similar effect on viral gene
transcription via its regulatory proteins such as Smad-3,
and Smad-4. Our data demonstrate that ectopic produc-
tion of Smad-3 and Smad-4 in astrocytic cells positively
and negatively regulates transcriptional activity of the
viral promoter. Further, our data indicate that coproduc-
tion of Smad-3 and -4 results in a decrease in the activity
of Smad-3 upon the viral promoter, suggesting that intra-
cellular levels of these two factors may determine their
activities upon the LTR transcription. The observation on
the negative effect of Smad-3 and Smad-4 on LTR tran-
scription corroborates with the earlier reports on sup-
pression of HIV-1 replication by TGF-1 in infected cells
of monocytic/macrophage lineage (Poli et al., 1991).
While the mechanism involved in Smad’s regulation of
HIV-1 gene transcription is not fully understood, one may
postulate that association of Smad-3 with another acti-
vator protein in astrocytes can elevate its activity and that
Smad-4 by disturbing this interaction moderates the ac-
tivity of Smad-3. This observation is interesting in light of
the earlier reports on the activation of type VII collagen
promoter in cells coproducing Smad-3 and Smad-4 (Vin-
devoghel et al., 1998) pointing to the diverse activity of
these factors on different promoters. It is also noteworthy
that the activity of Smad-3 and Smad-4 can be modulated
by other activators such as AP-1 and c-jun (Wong et al.,
1999). In a more recent study, it was shown that associ-
ation of Smads with AP-1 confers TGF-1 responsive-
ness in a promoter-specific manner (Verrechia et al.,
2001; Zhang et al., 1998). Also, it is noteworthy that AP1
by associating with NF-B can stimulate the HIV-1 LTR
(Jung et al., 1995). Therefore, it seems that AP1 may play
a dual role in the regulation of the LTR via the TGF/
Smad-3 and TNF/NF-B pathways. Our data presented
in Figs. 3 and 5 demonstrate that Smad-3 and Smad-4
functionally and physically interact with C/EBP. One im-
pact of such interaction is dissociation of C/EBP from its
DNA target sequence located within the HIV-1 LTR in
cells expressing Smad-3 and Smad-4. This event can
temper the ability of C/EBP to stimulate viral promoter via
its binding to the DNA sequences. This is in agreement
with the recent reports on the ability of Smad proteins in
suppressing C/EBP DNA-binding activity and its ability to
stimulate haptoglobin gene expression (Zauberman et
al., 2001). Our more recent results unraveled an alterna-
tive mechanism whereby C/EBP can elevate transcrip-
tion of several cellular and viral genes which do not
contain C/EBP-binding sites, suggesting that C/EBP by
increasing the levels and/or activity of other general
activators, such as Sp1 and TBP, may also have an
indirect regulatory impact on transcription of eukaryotic
promoters (Coyle-Rink, unpublished observations). The
ability of Smads to dissociate C/EBP from its DNA-bind-
ing sites without being associated with the DNA complex
suggests an off DNA association of C/EBP and Smad
proteins. In fact, our results from GST pull-down and
immunoprecipitation/Western blot analyses indicate the
interaction of C/EBP with Smad-4. Also, our results dem-
onstrate that in the presence of Tat, the effect of Smads
on the transcription of the HIV-1 promoter can be altered.
The functional interaction of Tat and Smads, in particular,
Smad-4, is of particular interest indicating that Tat, by
inhibiting a negative effector such as Smad-4, may indi-
rectly enhance viral gene transcription. Smad-3, on the
other hand, can somewhat stimulate viral gene expres-
sion even in the presence of the strong positive effector
protein, Tat.
Clearly, regulation of LTR transcription is mediated
through complex signaling pathways that may function
differentially in various cellular contexts. Our efforts on
utilizing astrocytes, where the HIV-1 genome is weakly
expressed compared to peripheral cells, unravels sev-
eral regulatory mechanisms involving various pathways
that prevent high level expression of the viral promoter
and replication of the viral genome. Currently, we are
focusing our attention on understanding the interaction
of viral transactivator, Tat, with the various signaling
pathways that exhibit regulatory effects on LTR gene
transcription.
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